BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34084195)

  • 1. Skin and metabolic syndrome: A review of the possible associations.
    Adibi N; Robati RM
    J Res Med Sci; 2021; 26():16. PubMed ID: 34084195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome and Skin Diseases.
    Hu Y; Zhu Y; Lian N; Chen M; Bartke A; Yuan R
    Front Endocrinol (Lausanne); 2019; 10():788. PubMed ID: 31824416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.
    Stefanadi EC; Dimitrakakis G; Antoniou CK; Challoumas D; Punjabi N; Dimitrakaki IA; Punjabi S; Stefanadis CI
    Diabetol Metab Syndr; 2018; 10():9. PubMed ID: 29483947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin disease related to metabolic syndrome in women.
    Misitzis A; Cunha PR; Kroumpouzos G
    Int J Womens Dermatol; 2019 Sep; 5(4):205-212. PubMed ID: 31700973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous manifestations of metabolic syndrome].
    Holzer G; Straßegger B; Volc-Platzer B
    Hautarzt; 2016 Dec; 67(12):982-988. PubMed ID: 27815622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between metabolic syndrome and prevalent skin diseases: A systematic review and meta-analysis of case-control studies.
    Sodagar S; Ghane Y; Heidari A; Heidari N; Khodadust E; Ahmadi SAY; Seirafianpour F; Baradaran H; Goodarzi A
    Health Sci Rep; 2023 Sep; 6(9):e1576. PubMed ID: 37752973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecologic and andrologic dermatology and the metabolic syndrome.
    Roth MM; Leader N; Kroumpouzos G
    Clin Dermatol; 2018; 36(1):72-80. PubMed ID: 29241756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
    Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
    Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study.
    Keen MA; Shah IH; Sheikh G
    Indian Dermatol Online J; 2017; 8(2):104-110. PubMed ID: 28405549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens and women's health.
    Redmond GP
    Int J Fertil Womens Med; 1998; 43(2):91-7. PubMed ID: 9609208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin tags and Acanthosis nigricans: association with insulin resistance and overweight in Mexican children].
    Valdés Rodríguez R; Moncada González B; Rivera Rodríguez SP; Aradillas García C; Hernández-Rodríguez H; Torres Álvarez B
    Gac Med Mex; 2011; 147(4):297-302. PubMed ID: 21894227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatologic manifestation of hyperandrogenism: a retrospective chart review.
    Clark CM; Rudolph J; Gerber DA; Glick S; Shalita AR; Lowenstein EJ
    Skinmed; 2014; 12(2):84-8. PubMed ID: 24933845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in dermatology: Treatment and Management for Dermatologists.
    Engin B; Özkoca D; Kutlubay Z; Serdaroğlu S
    Dermatol Ther; 2019 Mar; 32(2):e12812. PubMed ID: 30620081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miscellaneous skin disease and the metabolic syndrome.
    Seremet S; Gurel MS
    Clin Dermatol; 2018; 36(1):94-100. PubMed ID: 29241760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and skin diseases.
    Napolitano M; Megna M; Monfrecola G
    ScientificWorldJournal; 2015; 2015():479354. PubMed ID: 25977937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of glucose/insulin metabolic alterations in men with multiple skin tags on the neck.
    Sudy E; Urbina F; Maliqueo M; Sir T
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):852-5, 852-6. PubMed ID: 18397315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome and Skin: Interactions and Implications.
    Ambalal SM
    Indian J Dermatol; 2022; 67(2):138-145. PubMed ID: 36092223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.